March 6 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday its sales revenue edged up by an annual 1% in the first two months of 2018.
Domestic sales revenues remained unchanged year-on-year in the January-February period, while exports added 2%, the company said in a bourse filing.
In February alone, Sopharma's sales increased 2% year-on-year as sales on the domestic market grew 8%, while exports remained unchanged.
The company did not disclose information about volume of sales or amount of sales revenue.
As at 13:20 CET on Tuesday, Sopharma shares traded flat at 4.1 levs ($2.6/2.1 euro).
(1 euro = 1.95583 levs)